Viewing StudyNCT00734097



Ignite Creation Date: 2024-05-05 @ 7:47 PM
Last Modification Date: 2024-10-26 @ 9:53 AM
Study NCT ID: NCT00734097
Status: COMPLETED
Last Update Posted: 2012-10-10
First Post: 2008-08-11

Brief Title: A Study of Nexium Esomeprazole 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease GORD After Treatment With a Full Dose of Proton Pump Inhibitor PPI
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Gastroesophageal Reflux Disease
Keywords:
Name View
inhibitor View
heartburn View
reflux View
proton View
pump View